J&J looks past Olysio

Johnson & Johnson (NYSE:JNJ) fell $2.75 to $101.29 on Tuesday after issuing 2015 guidance of 1-2% operational sales growth for its combined pharma,

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE